Pregled bibliografske jedinice broj: 214127
Doppler Ultrasonography of the Vertebrobasilar Circulation in Patients with Sudden Sensorineural Hearing Loss
Doppler Ultrasonography of the Vertebrobasilar Circulation in Patients with Sudden Sensorineural Hearing Loss // Journal of otolaryngology, 34 (2005), 1; 51-59 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 214127 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Doppler Ultrasonography of the Vertebrobasilar Circulation in Patients with Sudden Sensorineural Hearing Loss
Autori
Grgić, Marko ; Petric, Vlado ; Pastorčić-Grgić, Marija ; Demarin, Vida ; Pegan, Boris
Izvornik
Journal of otolaryngology (0381-6605) 34
(2005), 1;
51-59
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Doppler ultrasonography; sudden sensorineural hearing loss; vertebrobasilar circulation
Sažetak
The etiology of sudden sensorineural hearing loss (SSNHL) is still unclear and is most probably diverse. Our objective was to determine the relationship between vertebrobasilar circulation and hearing in patients with SSNHL treated with pentoxifylline. Our case-control study consisted of 32 consecutive patients with SSNHL. Transcranial Doppler (TCD) ultrasonography of vertebrobasilar circulation and hearing levels were examined at onset of SSNHL (before treatment), after 10 days of therapy, and after 3 months. Patients with SSNHL had more frequent pathologic TCD ultrasonographic finding compared with a normal population. Thirteen patients with SSNHL had normal TCD ultrasonographic findings, eight had borderline findings, and six had pathologic findings, and in five patients, initially, pathologic TCD ultrasonohraphic findings improved during therapy. Patients with normal TCD ultrasonographic findings had an avreage hearing improvement of 17 dB, whereas patients with borderline and pathologic TCD ultrasonographic finding had 3 and 0 dB of avreage hearing improvement, respectively. Athough the number of patients is small, our results led to the conclusion that SSNHL has vascular etiology, at least in some patients. Consequently, the therapy for SSNHL should depend on etiology ; that is, vasoactive medications should be reserved for patients with supposed vascular etiology. TCD ultrasonography could have a role in the decision regarding the optimal treatement of SSNHL.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE